Attempting to redistribute the same weekly amount into multiple injections may change that curve in ways we dont fully understand, potentially affecting both efficacy and side effects
When prescribed by a licensed provider and clinically appropriate, NexLife may facilitate access to compounded semaglutide or compounded tirzepatide prepared by U.S.-licensed compounding pharmacies operating under state board oversight and applicable sterile compounding standards, including USP
For this reason, patients are advised to inform their healthcare provider of all medications, supplements, or herbs they are taking before starting NAD+ injections, even though no incompatibilities are documented thus far
Common side effects (10% or more of patients) Nausea Diarrhea Constipation Vomiting Stomach pain or discomfort Indigestion or acid reflux Headache Fatigue or low energy Dizziness Mild injection site reactions (redness, itching, bruising) Serious side effects (rare but require immediate medical attention) Pancreatitis: severe, persistent abdominal pain that may radiate to the back, often with nausea or vomiting Gallbladder problems: upper right abdominal pain, fever, jaundice, or unusual stool color Severe allergic reactions: rash, swelling of the face or throat, difficulty breathing Kidney issues: often related to dehydration from prolonged vomiting or diarrhea Severe hypoglycemia in patients also taking insulin or sulfonylureas Suicidal thoughts or mood changes: contact a healthcare provider promptly Boxed warning: Liraglutide caused thyroid C-cell tumors in animal studies
